thiazolyl blue has been researched along with oxadiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alderete, JB; Alves, RB; Cruz, AF; De Souza, AO; Pedrosa, MT; Prado, MA; Silva, CL | 1 |
| Mukherjee, AB; Sarkar, C; Zhang, Z | 1 |
2 other study(ies) available for thiazolyl blue and oxadiazoles
| Article | Year |
|---|---|
Cytotoxicity, antitumoral and antimycobacterial activity of tetrazole and oxadiazole derivatives.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Drug Design; Drug Screening Assays, Antitumor; Humans; Mycobacterium; Oxadiazoles; Structure-Activity Relationship; Tetrazoles; Tetrazolium Salts; Thiazoles | 2005 |
Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients.
Topics: Apoptosis; Cells, Cultured; Chromatography, Thin Layer; Codon, Nonsense; Codon, Terminator; Dose-Response Relationship, Drug; Enzyme Induction; Fluorescent Antibody Technique; Humans; Membrane Proteins; Microscopy, Electron, Transmission; Neuronal Ceroid-Lipofuscinoses; Oxadiazoles; Tetrazolium Salts; Thiazoles; Thiolester Hydrolases; Time Factors | 2011 |